We investigated the effects of loss of tenascin C on the healing of the stroma using incision-injured mice corneas. Tenascin C was upregulated in the stroma following incision injury to the cornea. Wild-type (WT) and tenascin C-null (knockout (KO)) mice on a C57BL/6 background were used. Cell culture experiments were also conducted to determine the effects of the lack of tenascin C on fibrogenic gene expression in ocular fibroblasts. Histology, immunohistochemistry and real-time reverse transcription PCR were employed to evaluate the healing process in the stroma. The difference in the incidence of wound closure was statistically analyzed in hematoxylin and eosin-stained samples between WT and KO mice in addition to qualitative observation. Healing of incision injury in corneal stroma was delayed, with less appearance of myofibroblasts, less invasion of macrophages and reduction in expression of collagen Ia1, fibronectin and transforming growth factor b1 (TGFb1) in KO mice compared with WT mice. In vitro experiments showed that the loss of tenascin C counteracted TGFb1 acceleration of mRNA expression of TGFb1, and of collagen Ia1 and of myofibroblast conversion in ocular fibroblasts. These results indicate that tenascin C modulates wound healing-related fibrogenic gene expression in ocular fibroblasts and is required for primary healing of the corneal stroma.
The cornea is an avascular tissue of the eye and transparent to refract light properly. An organized extracellular matrix structure is essential to the maintenance of the transparency. Once corneal stroma is injured, keratocytes adjacent to the wound are activated and undergo myofibroblast transformation to repair the damaged stroma. [1] [2] [3] [4] [5] During healing, myofibroblasts express and polymerize extracellular matrix components for primary repair of the stroma and then remodel the connective tissue. However, excessive tissue fibrosis is also induced in certain conditions. Cell behavior during the process of wound healing in an injured ocular tissue is regulated in a complex way by various growth factors, which have critical roles in pro-fibrogenic and proinflammatory reactions. 6, 7 It is widely believed that transforming growth factor b1 (TGFb1) is one of the most potent cytokines involved in tissue repair and fibrosis, ie, stromal healing of the cornea. 8 Tenascin C is one of the wound healing-related matrix macromolecules that is usually temporarily upregulated in an injured tissue, in addition to fibronectin. It is a disulfidebonded hexamer of a matrix component composed of subunits with molecular weights in the range of 120-300 kDa. 9, 10 Moreover, tenascin C is also abundantly detected at the invasive margin of cancer, suggesting its role at the progression/acquisition of invasive or migratory characteristics of cancer cells. 11, 12 It was reported that lacking tenascin C suppresses development of experimental liver fibrosis in mice with attenuation of fibroblastmyofibroblast conversion and reduced expression of fibrogenic cytokines. 13 These findings suggest that loss of tenascin C may impair the fibroblast-myofibroblast conversion and primary tissue repair of the corneal stroma. Tenascin C is also expressed in keratocytes under pathological conditions. 14, 15 Although Matsuda et al 16 has reported using qualitative histology under light microscopy that there was overall no difference in the process of tissue repair of an incision injury in the corneal stroma in the tenascin C knockout (KO) mouse, attenuation of keratocyte/corneal fibroblast migration and fibronectin deposition was detected following corneal suture wounds. These findings support the hypothesis that the loss of tenascin C impairs the healing of the corneal stroma. To address this question, in the present study we also took an advantage of the availability of a tenascin C-null (KO) mouse of C57BL/6 background in our laboratory. In the present study, to clear a disadvantage of the qualitative assessment of the wound-healing process in the corneal stroma, we employed statistical analysis of the incidence of closure of incision injury in the central corneal stroma of WT and KO mice during healing intervals. Our statistical analysis showed that primary healing of an incision injury in the corneal stroma is impaired in the absence of tenascin C, in association with suppression of fibrogenic gene expression. Lack of tenascin C in cultured ocular fibroblasts counteracted TGFb1 acceleration of expression of fibrogenic components and of myofibroblast generation. 
MATERIALS AND METHODS

Incision Injury in the Central Cornea
Wild-type C57BL/6 (WT) mice and KO mice of C57BL/6 background (RIKEN, Tokyo, Japan) were generally and topically anesthetized as previously reported. 6, 7 A full-thickness penetrating incision injury (1.5 mm in length) was produced in the central cornea of one eye by using a surgical blade (Satin Crescent, Alcon, Fort Worth, TX, USA) following administration of a mydryatic. The wound was not sutured. Ofloxacin ointment was topically administered immediately after injury and the affected eye was allowed to heal at day 0, 5 and 10. The eye was enucleated and fixed in 4% paraformaldehyde for 48 h. Twenty five or 25 WT, and 24 or 23 KO eyes were prepared for histology on day 5 or 10, respectively. Fixed specimens were routinely embedded in paraffin. Deparaffinized sections (7 mm thickness) were stained with hematoxylin and eosin (HE) and observed under light microscopy. Histology and the degree of the closure of the incision were evaluated. The numbers of the eyes with closure of the incision were determined and were statistically analyzed as described below.
Immunohistochemistry
Deparaffinized sections were processed for immunohistochemistry as previously reported. 6, 7 Antibodies used were anti-Human Tenascin C (4F10TT) mouse IgG monoclonal antibody (Clone IST-9, 1:20 dilution in phosphate-buffered saline (PBS); IBL, Gunma, Japan), rat monoclonal anti-macrophage F4/80 antibody (Clone A3-1, 1:400 dilution in PBS; BMA Biomedicals, August, Switzerland), mouse monoclonal anti-cellular fibronectin antibody (1:100 dilution in PBS; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and mouse monoclonal anti-a-smooth muscle actin (aSMA) antibody (1:100 dilution in PBS; Neomarker, Fremont, CA, USA). The antibody reacted with tissue antigen was visualized with 3,3 0 -diaminobenzidine reaction by using a commercially available immunostaining kit for sections of mouse tissue (Nichirei Biosciences, Tokyo, Japan). The specimens were counterstained with methylgreen. Secreted, active form of TGFb1 was immunostained as previously reported by using an antisecreted, active form of TGFb1 antibody produced by us. 6, 7 Specimens were observed under light microscopy (BX50; Olympus, Tokyo, Japan).
Real-Time Reverse-Transcription PCR Analysis of In Vivo Gene Expression
Healing cornea of a WT or KO mouse at day 5 or 10 was processed for total RNA extraction by using ISO GENE (Nippon Gene, Tokyo, Japan) as previously reported. 6, 7 Twenty corneas of 20 mice were prepared for each timepoint. One RNA sample was obtained from two corneal buttons. Taqman real-time reverse-transcription PCR (RT-PCR; TaqMan one-step RT-PCR master mix reagents kit, Applied Biosystems, Foster City, CA, USA) was performed to assay the mRNA expression level of collagen Ia1, TGFb1, aSMA and F4/80 by using Applied Biosystems 7300 Fast Real-Time PCR System(Applied Biosystems) as previously reported. 6, 7 Cell Culture Experiments Ocular fibroblasts were obtained from a post-natal day 1 (P1) mouse as previously reported. 16 The mesenchymal cells of cornea and aclera are both of a same developmental origin, ie, neural crest. The eye shells (including cornea and sclera) of P1 WT or KO mice were minced and explanted in collagen-coated 60-mm culture dish (Iwaki Glass, Tokyo, Japan) for the outgrowth of ocular fibroblasts. Eagle's essential medium was supplemented with 10% fetal calf serum, antibiotics and an antimycotic. Intraocular structures were carefully removed before being minced. Our preliminary experiment indicated the cells to be used in the study following one passage for analysis of gene expression, because the cells started to express aSMA after two passages.
Cells were subcultured and grown to confluence in 60-mm culture dishes, and then treated with recombinant human TGFb1 (1.0 ng/ml, R&D System, Minneapolis, MN, USA) or vehicle control in the Eagle's medium supplemented with 3% fetal calf serum for 24 h The cells were then processed for total RNA extraction and Taqman real-time RT-PCR for aSMA, TGFb1, TGFb2 and collagen Ia1 as described above. 17, 18 Ten dishes were prepared for each culture condition. Another set of cultures was incubated for 48 h with or without exogenous TGFb1 at 1.0 ng/ml and was processed for western blotting for aSMA protein as previously reported. 17, 18 Statistical Analysis In HE histology, the numbers of the eyes with or without closure (or being occupied with newly formed granulation tissue) of the incision were determined and were statistically analyzed by using Fisher's exact test with significance as Po0.05. Data obtained from real-time RT-PCR were shown as means±s.d. ANOVA was employed in multiple group comparisons. The value of Po0.05 was considered as statistically significant.
RESULTS
Protein Expression of Tenascin C in Healing Cornea
Following an Incision Injury Tenascin C protein is not detected in a cornea immediately following incision (Figure 1a and a 0 ). In day 5 post injury, tenascin C accumulation is observed in the stroma adjacent to the granulation tissue formed in the wound (Figure 1b and b 0 ). At day 10, tenascin C protein is more markedly observed in the stroma that faces the newly formed granulation tissue and beneath the regenerated epithelium on the granulation tissue as compared with its expression at day 5 ( Figure 1c and c 0 ).
Healing of KO and WT Mouse Eyes Following an Incision Injury in Cornea
Tenascin C is reportedly upregulated in a healing, injured, corneal stroma. We therefore first examined the role of tenascin C in healing of corneal stroma following an incision injury. No abnormalities were observed in the eye of a KO mouse. The histology of an uninjured cornea and that at immediately after the injury of a KO mouse was similar to that of the WT mouse (Figure 2a and b) . At day 5, the stromal injury was sealed (or closed) with granulation tissue in 17 of 25 WT mice, whereas it was found to be unclosed (remained unhealed) in 21 of 24 KO corneas (Figure 2c and d) . In the specimens of an unclosed wound, the epithelium showed more advanced migration on the cut surface of the stroma in KO corneas. The data of the incidence of closure/unclosure of Tenascin C and cornea wound healing T Sumioka et al the injury were statistically significant as analyzed by using the Fisher's exact test (P ¼ 0.00008225). Keratocyte population seemed to be less marked in the stroma adjacent to the wound edge in a KO cornea as compared with that in a WT cornea (indicated by a star in Figure 2d ). At day 10, the incision was sealed with healing stromal tissue in 16 of 25 WT mice. On the other hand, the incision wound was found to be unclosed (unhealed) with an epithelial growth, and the stroma remained edematous in 21 of 23 KO corneas (Figure 2e and f). The data of the ration of healed/unhealed wounds were significant as analyzed by using the Fisher's exact test (P ¼ 0.00007417). Similarly, keratocyte repopulation seemed to be less marked in the stroma adjacent to the wound edge in a KO cornea at day 10 compared with that in a WT cornea, even though the wound was found to be attached to the iris (indicated by a star in Figure 2f ). Stroma of KO mice at day 5 and 10 was much thicker and seemed swollen as compared with WT stroma.
Expression of Fibrogenic Components in a Healing Cornea
Immunohistochemistry detected myofibroblast generation, as revealed by aSMA expression. Myofibroblasts were not observed immediately after the wounding ( Figure 3aA and Figure 2 Healing of an incision-injured cornea of wild-type (WT) or tenascin C-null (knockout (KO)) mouse. Immediately after the incision, the injury in a KO cornea (b) was similar to that in a WT mouse (a). At a higher magnification, epithelium and stroma were found to be perpendicularly cut in both WT (a 0 ) and KO (b 0 ) mice. At day 5, the wound was sealed with fibrotic scar tissue in a WT mouse (c). Arrows indicate the cutting edge of the Descemet's membrane, although the stromal wound was not closed in a KO mouse (d). In a KO cornea, the epithelium (arrowheads) of the each side of the injury was not connected to each other, remaining the injury unclosed. Higher magnification pictures show that healing epithelium covers the granulation tissue formed in the wound in a WT mouse (c 0 ), whereas in a KO cornea (d 0 ) the healing epithelium does not migrate over the edge of the stromal injury (arrowhead). Arrows indicate the cutting edge of the Descemet's membrane. At day 10, the granulation (glan) tissue formed in the incision wound seemed more packed in a WT cornea (e), whereas the stromal injury was sealed with an epithelial growth (asterisk) in a KO cornea (f). At a higher magnification the healing epithelium (Epi) covers the granulation tissue (glan) in a WT tissue and in a KO cornea, healing epithelial cells (Epi) seem to fail to connect to the epithelium from the opposite side of the injury and is terminated at the end of the cutting edge of the stroma (arrowhead). Stroma of KO mice at day 5 and 10 was much thicker and seems swollen and acellular as compared with WT stroma (star). Arrows indicate the cutting edge of the Descemet's membrane. Frames (a 0 -f 0 ) show the higher magnification pictures of the quadrilateral area in each of Frames (a-f). Epi, corneal epithelium; stroma, corneal stroma; lens, crystalline lens; glan, granulation tissue, black arrows, the break of the Descemet's membrane; scale bar, 100 mm (a-f) and 25 mm (a 0 -f 0 ).
Tenascin C and cornea wound healing T Sumioka et al aB) and were detected in day 5 post-incision in a WT cornea (Figure 3aC ). Myofibroblasts were observed in the granulation tissue formed in the injury wound, as well as in the stroma adjacent to the edge of the incision. On the other hand, aSMA-labeled myofibroblasts were much less observed in the injured stroma of a KO mouse at this timepoint ( Figure 3aD ). Real-time RT-PCR indicated that the expression level of aSMA mRNA was much higher in the WT healing cornea as compared with the KO stroma at day 5 ( Figure 3b ). At day 10, immunohistochemical detection of aSMA seemed to decrease as compared with that at day 5 in WT mice (Figure 3aE ). In a KO corneal stroma, the expression of aSMA as detected by immunohistochemistry seemed to increase at day 10 as compared with that at day 5 in KO corneas (Figure 3aF ). Real-time RT-PCR showed that at day 10, the mRNA of aSMA, not the protein, expression decreases in a WT cornea, whereas it was readily detected in a KO cornea. However, a significant difference between a WT and a KO sample was not detected at this timepoint ( Figure 3b ). Fibronectin is a typical wound healing-related adhesive matrix macromolecule. In the current study, fibronectin was not detected in the corneal tissue immediately after the incision injury in both WT and KO mice (Figure 4aA and aB). At day 5, the granulation tissue formed in the wound labeled for fibronectin in a WT cornea (Figure 4aC ), whereas not in a KO tissue (Figure 4aD ). At day 10, fibronectin was still faintly observed in the healing stroma of a WT cornea (Figure 4aE ), although its immunoreactivity seemed less marked as compared with that at day 5. Such immunoreactivity was not observed in a KO cornea at this timepoint (Figure 3aF) .
Although type I collagen is the major extracellular matrix component, its mRNA upregulation indicates the presence of fibrogenic healing process of the connective tissue. TGFb1 is the major growth factor that modulates fibrogenic reaction in an injured tissue. We therefore examine if lacking tenascin C alters the expression of these two components in a healing cornea. The results showed that mRNA expression of collagen Ia1 (Figure 4b ) and TGFb1 (Figure 5a ) was significantly higher in a WT cornea as compared with that in a KO cornea at day 5. At day 10, expression of these components decreased in a WT cornea. However, a significant difference of the expression level of these components between WT and KO samples was not detected at this timepoint (Figures 4a and 5b) . Relative aSMA mRNA expression in the cornea of WT and KO mice as examined by real-time RT-PCR. At day 5, mRNA expression of aSMA is significantly higher in a WT cornea as compared with that in a KO cornea. At day 10, its expression decreases in a WT cornea, whereas it is not altered by the loss of tenascin C. **Po0.01.
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As real-time RT-PCR measures total expression level of TGFb1 message, we next measured the level of secreted, active form of TGFb1 in the tissue by using a specific antibody (Figure 5b ). Corneal epithelium and stroma were unstained for the secreted, active form of TGFb1 in both WT and KO mice (Figure 5bA and bA 0 , and bB and bB 0 ) immediately after the incision wounding. At day 5, active TGFb1 was detected in the stroma adjacent to the wound in a WT cornea (Figure 5b and C) , whereas the stroma that faces the incision injury was free from the active form of TGFb1 in a KO mouse (Figure 5bD and bD 0 ). At a higher magnification, active TGFb1 was accumulated in the stroma beneath the regenerated epithelium (Figure 5bC 0 ). At day 10, active, secreted form of TGFb1 was detected in the healing stroma of both WT and KO cornea (Figure 4b and E, F) . In both cases, active TGFb1 was more markedly detected in subepithelial stroma in the central healing stroma (Figure 5bE 0 and bF 0 ).
Macrophage Invasion
Macrophages have a crucial role in the process of tissue repair by expressing various cytokines/growth factors, including TGFb1. F4/80 immunohistochemistry did not detect macrophages in WT and KO corneas immediately following injury ( Figure 6aA , aB and aB 0 ). At day 5, abundant F4/80-labeled macrophages were detected in the granulation tissue formed in the wound of a WT mouse (Figure 6aC) , whereas very few immunolabeled cells were seen in a KO cornea (Figure 6aD) . At a higher magnification, granulation tissue formed in the wounded stroma was occupied with F4/ 80-labeled cells in a WT cornea (Figure 5aA 0 ). Such labeled cells were seen in a KO stroma (Figure 6aD 0 ) At day 10, macrophage invasion was reduced in a WT cornea (Figure 6aE ). At this timepoint, macrophages were not seen in the healing stroma of a KO cornea (Figure 6aF) . We then obtained a semi-quantitative data for mRNA expression of F4/80 antigen by using real-time RT-PCR. mRNA expression Tenascin C and cornea wound healing T Sumioka et al of F4/80 antigen was higher in the healing WT cornea as compared with KO cornea at day 5, but there was no difference at day 10 ( Figure 6b ).
Cell Culture Experiments
In the ocular fibroblasts used here, adding exogenous TGFb1 significantly upregulated mRNA expression of collagen Ia1 and TGFb1, but TGFb2 mRNA expression was not altered by exogenous TGFb1. Loss of tenascin C blocked the TGFb1-induced upregulation of mRNA expression for both collagen Ia1 (Figure 7a ) and TGFb1 (Figure 7b ). Expression of TGFb2 was not significantly changed by the loss of tenascin C in the cells (Figure 7c) , either in the presence or absence of TGFb1. A similar pattern of mRNA expression of aSMA was observed. Addition of exogenous TGFb1 increased the mRNA expression level of aSMA (Figure 7d ) in WT fibroblasts, whereas loss of tenascin C attenuated the upregulation of mRNA expression of aSMA by exogenous TGFb1 (Figure 7d) . Furthermore, aSMA protein expression level increased following TGFb1 treatment of WT fibroblasts, but no upregulation of aSMA was detected in tenascin C KO fibroblasts (Figure 7e) .
DISCUSSION
In the present study, we first showed that the healing of the full-thickness incision in the cornea was statistically significantly delayed in the KO mice as compared with the WT mice. The incision injury in the corneal stroma was occupied with granulation tissue (primary healing) at day 5 in 17 of 25 WT corneas, whereas the wound edge was not adhered to each other in 21 of 24 KO mice. Even at day 10, fibrotic adhesion between in the wound were observed only in 2 of 23 KO mice compared with 16 of 25 WT corneas.
Further analysis was conducted to elucidate the mechanism underlying the impaired stromal healing in a KO mouse. Immunohistochemistry suggest that generation of aSMAlabeled myofibroblasts, the hallmark of stromal wound healing and tissue fibrosis, in the corneal stroma adjacent the wound was severely attenuated by the loss of tenascin C. The real-time RT-PCR analysis also showed less expression of aSMA mRNA in the KO cornea as compared with the WT cornea at day 5 post injury. HE histology shows that mesenchymal cells derived from the iris might exhibit a minimum contribution to the stromal healing, because each iris was not found to be directly adhered to the corneal injury in each WT specimen. In a KO cornea, the iris was attached to the corneal wound at day 10 probably because of the prolonged exposure of the stromal cut surface due to delayed healing. Fibronectin is a major wound healing-related adhesive matrix molecule in cornea like that in various tissues, and is detected in plasma (plasma fibronectin) and expressed in local cells (cellular fibronectin). Our present immunohistochemistry clearly showed that the loss of tenascin C reduced the upregulation of cellular fibronectin at the injury site of the cornea that coincides with the previous report by Matsuda et al. 16 Real-time RT-PCR indicated that mRNA Tenascin C and cornea wound healing T Sumioka et al expression of collagen Ia1 chain was also more marked in a WT cornea as compared with a KO cornea at day 5 post wounding, but not at day 10. These findings taken together indicate that tenascin C is involved in the expression of tissue fibrosis-related components in vivo. Matsuda et al 16 reported that the final healing outcome was similar between in a WT mouse and in their tenascin C-deficient mice of background of C3H or BALB/C, although detailed histological analysis showed findings similar to ours, suppression of expression of fibronectin and cornmeal fibroblast population with lacking tenascin C. It is to be answered if the background of mouse strain might affect the healing outcome in an incision injury in cornea of tenascin C-deficient mice. Indeed in an experimental model of pulmonary fibrosis, mouse strains affect the degree of the fibrosis. 19 As TGFb1 is the major growth factor involved in tissue fibrosis and modulating the expression level of collagen I and fibronectin, and myofibroblast generation, we next evaluated the expression level of TGFb1. 19 Real-time RT-PCR and showed that loss of tenascin C reduced its expression level in the healing cornea at day 5, but not at day 10. Furthermore, immunohistochemistry indicated that expression of secreted, activated form of TGFb1 was also suppressed by the loss of tenascin C at day 5, but not at day 10. This finding suggests the critical role of the attenuation of TGFb1 expression in a KO cornea in the KO phenotype of healing of the incision injury of the cornea. Although TGFb1 is one of the growth factors most involved in the phenotypic change of a fibroblast into a myofibroblast, tissue fibronectin is also required for this phenomenon. 20 Thus, in the present study less appearance of myofibroblasts in the KO tissue at day 10 might be explained by the low level of immunohistochemically detected cellular fibronectin. Besides its fibrogenic effects, TGFb1 is chemoattractant to macrophages, which, in turn, is one of the major source of TGFb1 in a healing tissue. Thus, we then examined the population of macrophages in the injured cornea of WT and KO mice. We previously reported an impairment of macrophage infiltration in a cauterized cornea by the loss of tenascin C. 21 Immunohistochemistry suggested that accumulation of F4/80-labeled macrophages was less in a KO wound as compared with a WT wound at day 5. Realtime RT-PCR indicated that expression of F4/80 mRNA decreased at day 10 as compared with that at day 5. F4/80 expression was reduced by the loss of tenascin C at day 5. Suppression of macrophage infiltration, in turn, might account for further reduction of TGFb1 level in tissue.
We then conducted in vitro experiments by using cultured fibroblasts obtained from a KO mouse eye. These experiments showed that adding exogenous TGFb1 upregulated mRNA expression of TGFb1 and collagen Ia1, but did not alter the expression level of TGFb2. Lacking tenascin C decreased mRNA expression of TGFb1 and collagen Ia1, but not TGFb2, in the cells in the presence of exogenous TGFb1. Generation of myofibroblasts from fibroblasts is also a hallmark of granulation tissue formation and tissue scarring. Adding TGFb1 significantly upregulated mRNA and protein expression of aSMA, the marker for the myofibroblast, in cultured ocular fibroblasts. We then showed that loss of tenascin C counteracted upregulation of aSMA mRNA and protein by exogenous TGFb1. These in vitro findings suggest that lacking tenascin C attenuates activation of TGFb-related cellular behaviors in vitro. A similar mechanism also might underlie the impaired healing of the KO corneal stroma in vivo besides the reduction of tissue TGFb1 level and suppression of macrophage infiltration.
The effects of lacking tenascin C on the healing process of the corneal or cutaneous tissue have been previously studied. Matsuda et al 16 reported that there was overall no difference in the stromal repair by using qualitative histology and light microscopy without statistical analysis. 14 They described that the loss of tenascin C attenuates expression of wound healing-related components (corneal fibroblast migration and fibronectin deposition) in a suture wound in a corneal stroma in mice. The report might support our statistical conclusion of the impairment of stromal repair in a KO mouse. Fosberg et al 22 reported the loss of tenascin C suppresses the expression of level of fibronectin in the healing granulation tissue, but there was overall no difference in healing of skin and nerve injuries in a tenascin C-deficient mouse. They also evaluated the healing process by using the histology methods, but not statistical analysis of the size of the wound. Possible suppression of healing by the reduction of fibronectin might be counteracted (or masked) by abundant wound healing-promoting factors and inflammatory cells supplied by the blood in the KO mouse skin wound. The difference of the wound-healing process between these two tissues might depend on the structure (including presence/absence of the blood vessels). Sta Iglesia et al 23 reported deletion of tenascin C did not perturb corneal epithelial wound healing, but they failed to examine the stromal tissue repair.
Previous reports also indicate that loss of tenascin C attenuates tissue fibrosis in the liver and lung, which show less severe fibrosis and suppression of TGFb signaling in the tenascin C KO mouse as compared with a WT mouse. In these projects, lacking tenascin C suppresses the progression of undesirable tissue fibrosis or generation of myofibroblasts from mesenchymal cells in vitro. The present finding that the loss of tenascin C attenuates the healing of the corneal stroma coincides with these previous reports.
The exact mechanism that explains blocking of TGFb signal by lacking tenascin C remains to be identified. We previously reported that loss of osteopontin, another a9 integrin-related extracellular matrix component like tenascin C, impairs healing of an incision injury similar to that employed in the present study, and that expression of fibrogenic components in cultured ocular fibroblasts was suppressed by the loss of this molecule. 24 Our in vitro experiment revealed that lacking osteopontin inhibited phosphorylation of Smad3 and p38 in cultured ocular fibroblasts that might explain the mechanism of attenuation of TGFb-related fibrogenic reaction in osteopontin-null fibroblasts. 25 As for the mechanism of impairment of TGFb-related healing and fibrogenic gene expression by the loss of tenascin C was reported in experimental lung fibrosis model in mice, [26] [27] [28] [29] this report also showed that lacking tenascin C decreases the level of total Smad3 (not Smad2), 30 but did not inhibit the phosphorylation of Smad3, as examined by western blotting. The authors of this report speculate that reduction of total Smad3 protein might account for the impairment of TGFb/ Smad3 signal and resultant inhibition of fibrogenic behaviors of fibroblasts in lung tissue. However, our experiments showed, on the other hand, that the loss of tenascin C does not affect both the level of phosphorylation of Smad2/3 and p38 and total level of Smad3 protein (data not shown). Therefore, the mechanism underlying the attenuation of fibrogenic gene expression in ocular fibroblasts by lacking tenascin C might not be similar to that of tenascin C-null lung fibroblasts and also the ocular fibroblasts derived from a mouse lacking osteopontin.
Interaction between integrin-derived signals and TGFbrelated signals are reported in various cell types. Activation of an integrin could initiate TGFb/Smad signaling via interaction with TGFb receptor. 31, 32 TGFb-induced phenotypic changes were not observed in cells in suspension and were dependent on b1-33 or a3b1-integrin
34
. TGFb-mediated cellular transdifferentiation to a more fibrogenic phenotype, such as the myofibroblast or EMT, appears to require integrins. For example, avb3-integrin interacts with TbRII and enhances TGFb-induction of lung fibroblast proliferation. 35 Further, siRNA to b3-integrin inhibited TGFb-induced EMT and migration of mouse mammary gland epithelial cells by preventing the TbR-interaction with the integrin and subsequent p38 MAPK activity without affecting Smad phosphorylation. 36 TbRII association with avb5-integrin was also found in sclerodermal fibroblasts, and subsequent FAK activity is required for myofibroblastic differentiation. 37 These reports strongly suggest the involvement of tenascin C integrin binding might exert a specific effect on Smad signal. Further in vitro study is needed to uncover this point.
